2015-01-01 00:00:00
Colonic bacterial composition in Parkinson’s diseaseCategories
View AllConditions
View AllDefinitions
View AllGuides & Resources
View AllInterventions
View AllMicrobes
View AllMetals
View AllResearch Feeds
View AllKaren Pendergrass, Standards Team
About
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.
Recent Posts
2014-01-01 00:00:00
Fecal microbiota imbalance in Mexican children with type 1 diabetes2014-01-01 00:00:00
Microbial dysbiosis is associated with human breast cancer2013-01-01 00:00:00
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study2012-01-01 00:00:00
Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndromeThe study highlights functional dysbiosis in constipated-irritable bowel syndrome, with increased sulfate-reducing bacteria and disrupted CFA profiles.
2012-01-01 00:00:00
Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndromeThe study investigated gut microbiota in diarrhea-predominant irritable bowel syndrome (BS), revealing distinct microbial shifts, including increased Enterobacteriaceae and reduced Faecalibacterium populations, indicating potential inflammatory mechanisms
2012-01-01 00:00:00
Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndromeThe study identified significant shifts in fecal bile acid composition and gut microbiota in BS-D patients. Elevated primary bile acids and dysbiosis were linked to stool frequency and consistency, suggesting bile acid modulation as a potential therapeutic target for symptom management.
2012-01-01 00:00:00
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementationThis study found that while probiotics may relieve BS symptoms, they do not revert the gut microbiota imbalances associated with the disorder.
2011-01-01 00:00:00
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndromeThis study reveals that diarrhea-predominant BS (BS) is linked to reduced microbial diversity and niche-specific dysbiosis in the gut.
2011-01-01 00:00:00
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndromeThis study identifies distinct microbiome signatures in pediatric BS, revealing unique microbial imbalances linked to disease subtypes.